Ion Beam Applications S.A. (IBA) announced the successful expansion of IBA Academy on the Road “Small Field Dosimetry Workshop,” organized and hosted with Lung Center of the Philippines in Manila, and the Philippine Organization of Medical Physicists (POMP) on March 7.

The U.S. Food and Drug Administration (FDA) reports it has revoked the Mammography Quality Standards Act (MQSA) certificate for AP Diagnostic Imaging Inc., a facility at 1692 Oak Tree Road in Edison, New Jersey. The facility has ceased performing mammography.

Investigators at The Saban Research Institute of Children's Hospital Los Angeles have demonstrated that magnetic resonance imaging (MRI) of the liver is more accurate than liver biopsy in determining total body iron balance in patients with disorders requiring blood transfusion therapy. This discovery follows the researchers earlier work in pioneering techniques to use MRI to noninvasively measure liver iron. Their study has been published online in Magnetic Resonance Imaging.

Fujifilm Medical Systems U.S.A. Inc. showcased the Aspire Cristalle at the 25th Annual Interdisciplinary Breast Center Conference sponsored by the National Consortium of Breast Centers, March 14-18 in Las Vegas.

The sixth Image Wisely Radiation Safety Case —Optimizing Radiation Use During a Difficult IVC Filter Retrieval — is now available to help radiologists, imaging technologists and medical physicists to assess their understanding of important radiation safety concepts — including dose monitoring and optimization. This is the latest in a series of free, online and mobile-compatible Image Wisely educational offerings, developed with the assistance of the American College of Radiology (ACR).

Researchers from Banner Alzheimer's Institute (BAI) have developed a new brain image analysis method to better track the progression of beta-amyloid plaque deposition, a characteristic brain abnormality in Alzheimer's disease, according to a study published in the March issue of the Journal of Nuclear Medicine. Investigators also believe this new approach may make it easier to evaluate investigational anti-amyloid treatments in clinical trials.